KIZOO

Total investments

50

Average round size

6M

Portfolio companies

30

Rounds per year

2.08

Lead investments

14

Follow on index

0.40

Exits

3

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyMobileHuman ResourcesHealth CareAppsCollaborationLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

In 2000 was created KIZOO, which is appeared as VC. The company was established in Europe in Germany. The main department of described VC is located in the Karlsruhe.

Besides them, we counted 2 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the KIZOO, startups are often financed by Runa Capital, Point Nine Capital, HW Capital. The meaningful sponsors for the fund in investment in the same round are Runa Capital, Point Nine Capital, Capnamic Ventures. In the next rounds fund is usually obtained by Runa Capital, Point Nine Capital, Capnamic Ventures.

This KIZOO works on 20 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2018.

The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight AgeX Therapeutics, Lysoclear, Suitepad. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Cloud Computing, Software.

Show more

Investments analytics

Analytics

Total investments
50
Lead investments
14
Exits
3
Rounds per year
2.08
Follow on index
0.40
Investments by industry
  • Biotechnology (17)
  • Biopharma (9)
  • Therapeutics (8)
  • Apps (8)
  • Human Resources (8)
  • Show 41 more
Investments by region
  • Germany (26)
  • United States (21)
  • United Kingdom (2)
  • Austria (1)
Peak activity year
2017
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
218M
Group Appearance index
0.54
Avg. company exit year
6
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Elastrin Therapeutics 07 Apr 2022 Biotechnology, Therapeutics, Biopharma Seed 10M United States, South Carolina
Prescreen 21 Jul 2015 Software, Recruiting, SaaS, Enterprise Software Seed Vienna, Austria
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.